Alnylam Pharmaceuticals, Inc.
ALNY · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$278 | -$440 | -$1,131 | -$853 |
| Dep. & Amort. | $57 | $97 | $86 | $90 |
| Deferred Tax | -$107 | $0 | $0 | -$56 |
| Stock-Based Comp. | $272 | $222 | $231 | $166 |
| Change in WC | -$214 | $11 | -$36 | -$163 |
| Other Non-Cash | $262 | $215 | $309 | $174 |
| Operating Cash Flow | -$8 | $104 | -$541 | -$642 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$34 | -$62 | -$72 | -$76 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$1,712 | -$1,824 | -$1,977 | -$1,656 |
| Inv. Sales/Matur. | $1,572 | $1,554 | $2,232 | $1,464 |
| Other Inv. Act. | $58 | -$4 | -$13 | -$4 |
| Investing Cash Flow | -$117 | -$336 | $169 | -$273 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $254 | $500 |
| Stock Issued | $303 | $147 | $259 | $246 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$9 | $25 | -$88 | $501 |
| Financing Cash Flow | $294 | $172 | $426 | $1,247 |
| Forex Effect | -$15 | $6 | -$7 | -$9 |
| Net Chg. in Cash | $154 | -$54 | $46 | $323 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $815 | $869 | $822 | $499 |
| End Cash | $969 | $815 | $869 | $822 |
| Free Cash Flow | -$43 | $42 | -$613 | -$718 |